Top Markets
Coin of the day
ImageneBio Inc ImageneBio Inc

ImageneBio Inc

IMA
Rank in Stocks #24235
ImageneBio Inc (IMA) is a biotechnology company with therapies currently... ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Share Price
$5.61
Last synced: 2026-08-21
Market Cap
$63.22M
Change (1 day)
-0.09%
Change (1 year)
-60.61%
Country
US
Trade ImageneBio Inc (IMA)

Category

Price of IMA with the market cap of B
ImageneBio Inc ImageneBio Inc
IMA
$5.61
Market Capitalization of ImageneBio Inc(IMA)
Market Cap: $63.22M
As of August 2026 ImageneBio Inc has a market cap of $63.22M. This makes ImageneBio Inc the world's 24235th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ImageneBio Inc from 2021 to 2026
IMA compared with Top 5 Most Popular stocks
Price of IMA Asset B Mkt. of B Results
ImageneBio Inc ImageneBio Inc
$462,040 $63.22M
$5.211T +8,243,246.37%
ImageneBio Inc ImageneBio Inc
$403,114 $63.22M
$4.547T +7,191,945.48%
ImageneBio Inc ImageneBio Inc
$369,045 $63.22M
$4.162T +6,584,106.92%
ImageneBio Inc ImageneBio Inc
$318,537 $63.22M
$3.593T +5,682,978.48%
ImageneBio Inc ImageneBio Inc
$247,614 $63.22M
$2.793T +4,417,638.60%